Ion Channels: New Actors Playing in Chemotherapeutic Resistance

In the battle against cancer cells, therapeutic modalities are drastically limited by intrinsic or acquired drug resistance. Resistance to therapy is not only common, but expected: if systemic agents used for cancer treatment are usually active at the beginning of therapy (i.e., 90% of primary breas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Kischel, Philippe, Girault, Alban, Rodat-Despoix, Lise, Chamlali, Mohamed, Radoslavova, Silviya, Abou Daya, Hiba, Lefebvre, Thibaut, Foulon, Arthur, Rybarczyk, Pierre, Hague, Frédéric, Dhennin-Duthille, Isabelle, Gautier, Mathieu, Ouadid-Ahidouch, Halima
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6468599/
https://ncbi.nlm.nih.gov/pubmed/30884858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11030376
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados